Search Results - "Hedt, Amos"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
  2. 2
  3. 3

    Radiological properties of Next Generation Theranostics (Cu-64/Cu-67) by Biggin, Colin, Harris, Matt, Hedt, Amos, Jeffery, Charmaine

    Published in The Journal of nuclear medicine (1978) (01-05-2017)
    “…Objectives: To examine the radiological properties of Next Generation Theranostics: Methods: Next generation theranostics can potentially offer improvements on…”
    Get full text
    Journal Article
  4. 4

    A Novel Theranostic Trial Design Using 64Cu/67Cu with Fully 3D Pre-Treatment Dosimetry by Bailey, Dale, Schembri, Geoff, Willowson, Kathy, Hedt, Amos, Lengyelova, Eva, Harris, Matt

    Published in The Journal of nuclear medicine (1978) (01-05-2019)
    “…Aim: The main purpose of this trial is to study the first-in-man biodistribution and radiation dosimetry estimates for the beta- & gamma-emitter Copper-67…”
    Get full text
    Journal Article
  5. 5

    Implementation of a whole body SPECT-CT imaging protocol for post-treatment dosimetry of 67Cu-SARTATE by Willowson, Kathy, Bailey, Dale, Schembri, Geoff, Hedt, Amos, Harris, Matthew, Parker, Michelle

    Published in The Journal of nuclear medicine (1978) (01-05-2019)
    “…Aim: To implement a fully 3D imaging protocol, based on whole body SPECT-CT without the use of planar imaging, for patient specific whole body dosimetry…”
    Get full text
    Journal Article
  6. 6

    Development of 67Cu quantitative SPECT for clinical dosimetry by Willowson, Kathy, Harris, Matt, Jeffery, Charmaine, Biggin, Colin, Hedt, Amos, Stoner, Jon, Bailey, Dale

    Published in The Journal of nuclear medicine (1978) (01-05-2018)
    “…Objectives: ackground / Aims: Copper-67 (67Cu) shows promise as a radionuclide therapy agent, in particular when paired with the diagnostic PET imaging agent…”
    Get full text
    Journal Article
  7. 7

    Development of ^sup 67^Cu quantitative SPECT for clinical dosimetry by Willowson, Kathy, Harris, Matt, Jeffery, Charmaine, Biggin, Colin, Hedt, Amos, Stoner, Jon, Bailey, Dale

    Published in The Journal of nuclear medicine (1978) (01-05-2018)
    “…Objectives: ackground / Aims: Copper-67 (67Cu) shows promise as a radionuclide therapy agent, in particular when paired with the diagnostic PET imaging agent…”
    Get full text
    Journal Article
  8. 8

    Harnessing 64 Cu/ 67 Cu for a theranostic approach to pretargeted radioimmunotherapy by Keinänen, Outi, Fung, Kimberly, Brennan, James M, Zia, Nicholas, Harris, Matt, van Dam, Ellen, Biggin, Colin, Hedt, Amos, Stoner, Jon, Donnelly, Paul S, Lewis, Jason S, Zeglis, Brian M

    “…Over the past decade, theranostic imaging has emerged as a powerful clinical tool in oncology for identifying patients likely to respond to targeted therapies…”
    Get full text
    Journal Article
  9. 9

    Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy by Keinänen, Outi, Fung, Kimberly, Brennan, James M., Zia, Nicholas, Harris, Matt, van Dam, Ellen, Biggin, Colin, Hedt, Amos, Stoner, Jon, Donnelly, Paul S., Lewis, Jason S., Zeglis, Brian M.

    “…Over the past decade, theranostic imaging has emerged as a powerful clinical tool in oncology for identifying patients likely to respond to targeted therapies…”
    Get full text
    Journal Article
  10. 10